Allograft Fibrosis Following Pediatric Cardiac Transplantation

Stopped early

Conditions studied: Children Who Underwent Heart Transplantation Prior to Age 18, Received Care at Children's Healthcare of Atlanta

In brief

Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could potentially have an adverse effect on long-term cardiac function. We wish to study the degree of fibrosis to see if we can predict survival following pediatric heart transplantation.

Key facts

Study ID

NCT00328185

Run by

Children's Healthcare of Atlanta

People needed

100

Starts

2006-01-01

Expected to finish

2006-12-01

Last updated by the study team

2012-03-16

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children who underwent heart transplantation prior to age 18
• Followed up at Children's Healthcare of Atlanta

You may not qualify if…

• Children without a transplanted heart
• Follow-up not at children's Healthcare of Atlanta

Where it is running

• Children's Healthcare of Atlanta — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.